iCam Microarray Polymerase Chain Reaction and Metagenomics in the Diagnosis of Microbial Keratitis: A Case Series
Cornea Open · 2026-06 · 5 (2)
DOI: 10.1097/coa.0000000000000098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cornea Open, 2026-06. Verfasst von Ahmed Elshahat und 8 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To compare the diagnostic performance of an ophthalmology-specific microarray polymerase chain reaction (iCAM PCR) and metagenomic next-generation sequencing (mNGS) against conventional microbiological investigations in microbial keratitis in a case series of patients with microbial keratitis.
Methods
Corneal epithelial scrapes from 4 patients with microbial keratitis were analyzed using iCAM microarray PCR (multiplex PCR) and mNGS as part of the iCAM clinical trial (ISRCTN17422545). Parallel samples underwent standard microbiological testing, including microscopy, culture, and real-time PCR according to local protocol. The turnaround time, microbial detection, concordance between modalities, and the influence of results on clinical decision making are reported. Results: iCAM microarray PCR identified the causative organism in 3 of 4 cases ( Candida parapsilosis , Streptococcus pneumoniae , and Acanthamoeba castellanii ), in agreement with conventional methods. iCAM microarray PCR turnaround time was 6 hours. This allowed the prompt initiation of appropriate antimicrobial therapy and the exclusion of alternative pathogens. On the other hand, turnaround time for conventional microbiology ranged between 2 and 14 days. mNGS identified the pathogen in all 4 cases with a turnaround time of 1 to 2 days. Capnocytophaga was exclusively identified by mNGS in a rapidly progressive keratitis, where both iCAM and routine microbial tests had failed to detect the organism.
Conclusions
Microarray PCR and mNGS have the potential to improve microbial detection, reduce diagnostic delays, and ultimately enhance clinical outcomes in microbial keratitis. Larger studies are required to define their optimal integration into routine clinical practice.
Zitieren
APA
Elshahat, A., May, S., Patel, P., Doyle, R. M., Ward, D., Snell, L. B., Alcolea-Medina, A., Gouliouris, T., & Rajan, M. S. (2026). iCam Microarray Polymerase Chain Reaction and Metagenomics in the Diagnosis of Microbial Keratitis: A Case Series. Cornea Open, 5(2). https://doi.org/10.1097/coa.0000000000000098
Vancouver
Elshahat A, May S, Patel P, Doyle RM, Ward D, Snell LB, et al. iCam Microarray Polymerase Chain Reaction and Metagenomics in the Diagnosis of Microbial Keratitis: A Case Series. Cornea Open. 2026;5(2). doi:10.1097/coa.0000000000000098
BibTeX
@article{Elshahat2026,
author = {Elshahat, Ahmed and May, Sophie and Patel, Poorvi and Doyle, Ronan M. and Ward, Daniel and Snell, Luke B. and Alcolea-Medina, Adela and Gouliouris, Theodore and Rajan, Madhavan S.},
title = {iCam Microarray Polymerase Chain Reaction and Metagenomics in the Diagnosis of Microbial Keratitis: A Case Series},
journal = {Cornea Open},
year = {2026},
volume = {5},
number = {2},
doi = {10.1097/coa.0000000000000098}
}
EUVIMED